VLP Therapeutics raises $21M Series A-1 for cancer treatment vaccine, infectious diseases vaccine R&D

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Related Keywords

Miyako ,Iwate ,Japan ,Tokyo ,Kyoto ,Yutaka Iijima ,Hayami Masanori ,Robertg Hisaoka ,Sachiko Kuno ,Wataru Akahata ,Ryuji Ueno ,Vaccine Research Center ,Global Communications ,National Institutes Of Health ,Sk Impact Fund ,Capital Co Ltd ,Sojitz Corporation ,Tokyo Institute Of Technology ,Bank Ltd ,Therapeutics Japan ,Kyoto University Graduate School Of Medicine ,Kyoto University Institute For Virus Research ,Therapeutics Inc ,University Of Tokyo ,Nobelpharma Co Ltd ,Kyoto University Graduate School Of Human ,Kyoto University ,Graduate School ,Kyoto University Institute ,National Institutes ,Nature Medicine ,Tokyo Institute ,Kyoto University Graduate School ,Business ,Health ,Infectious Diseases ,Pr Newswire ,Philanthropy ,Cancer ,Sojitz Corp ,